Aortic Aneurysm Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

The global aortic aneurysm market is projected to be valued at US$ 5.1 Bn in 2025 and is anticipated to reach US$ 10.7 Bn by 2032, expanding at a CAGR of 11.17% between 2025 and 2032.

Market Insights

The aortic aneurysm market is experiencing strong growth, driven by rising prevalence of cardiovascular diseases and a rapidly aging global population. Increasing preference for minimally invasive procedures such as endovascular aneurysm repair (EVAR) has significantly reduced mortality rates and hospital stays, fueling adoption. Enhanced diagnostic imaging technologies and growing government initiatives for preventive screening are further contributing to the market’s momentum. With technological innovation and better access to advanced care, the global landscape for aortic aneurysm management is poised for steady expansion.

Aortic Aneurysm Market – Report Scope

The aortic aneurysm market encompasses treatment methods and medical devices designed for managing thoracic aortic aneurysm (TAA) and abdominal aortic aneurysm (AAA). The growing application of stent grafts and catheter-based interventions has shifted preference toward EVAR procedures over traditional open surgical repair (OSR). The market is witnessing continuous progress through next-generation graft designs, reduced complication rates, and improved long-term survival outcomes. As healthcare systems prioritize minimally invasive solutions, the market is set for sustainable growth across all major regions.

Market Growth Drivers

Growth in the global aortic aneurysm market is underpinned by multiple factors. Rising incidences of risk factors such as hypertension, obesity, smoking, and sedentary lifestyles are directly contributing to aneurysm cases. A rapidly expanding geriatric population, particularly in developed economies, is further increasing patient demand for advanced treatments. Enhanced awareness regarding early diagnosis through screening programs and access to specialized vascular care are accelerating treatment rates. Additionally, innovations in stent grafts, catheters, and imaging technologies continue to support the steady expansion of this market.

Market Restraints

While opportunities are promising, the aortic aneurysm market also faces certain limitations. High procedure and device costs, particularly in developing economies, remain a significant barrier to widespread adoption of EVAR. Limited awareness about aneurysm symptoms in early stages often leads to delayed diagnosis, reducing timely intervention opportunities. Complications related to endovascular grafts, such as leakage and migration, challenge long-term treatment outcomes. Furthermore, strict regulatory requirements and lengthy approval processes for new devices can slow down innovation and market entry.

Market Opportunities

The market presents considerable opportunities for manufacturers and healthcare providers. Emerging economies are showing strong potential as healthcare infrastructure improves and access to advanced vascular procedures expands. The development of drug-eluting stent grafts, bioresorbable materials, and AI-powered imaging systems holds promise for next-generation treatments. Strategic collaborations between hospitals and medical device companies are likely to accelerate adoption of innovative solutions. Preventive screening programs in North America and Europe, along with rising healthcare investments in Asia-Pacific, will continue to create favorable conditions for market growth.

Regional Outlook
• North America leads the global market, supported by robust healthcare infrastructure, high adoption of EVAR procedures, and favorable reimbursement systems in the U.S.
• Europe maintains a significant share, with strong demand fueled by an aging population and government-backed aneurysm screening initiatives in countries like the UK and Germany.
• Asia Pacific is projected to record the fastest growth, driven by rising patient awareness, healthcare investments, and technological advancements in China, India, and Japan.
• Latin America is witnessing increasing opportunities through medical tourism and expanding access to specialized cardiovascular treatments in Brazil and Mexico.
• Middle East & Africa show steady growth as investments in healthcare infrastructure and rising awareness of cardiovascular disease management gradually improve treatment availability.

Leading Companies

Prominent players in the Aortic Aneurysm Market include Medtronic, Endologix LLC, Gore Medical, MicroPort Scientific Corporation, Cook, JOTEC, Cardinal Health, Terumo Corporation, Lombard Medical, and AbbVie Inc. These companies are focusing on innovation in stent graft designs, enhancing catheter-based delivery systems, and forming strategic partnerships with healthcare institutions to strengthen their market presence. Continuous investment in R&D and expansion of distribution networks are enabling these players to maintain competitiveness.

Companies Covered in This Report
• Medtronic
• Endologix LLC
• Gore Medical
• MicroPort Scientific Corporation
• Cook
• JOTEC
• Cardinal Health
• Terumo Corporation
• Lombard Medical
• AbbVie Inc

Market Segmentation

By Type
• Thoracic Aortic Aneurysm (TAA)
• Abdominal Aortic Aneurysm (AAA)

By Treatment
• Open Surgical Repair (OSR)
• Endovascular Aneurysm Repair (EVAR)

By Product
• Stent Grafts
• Catheters

By End User
• Hospitals
• Ambulatory Surgery Centers
• Clinics

By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

Please note: Delivery Timelines - 5 working days. Show more